Table 1

Cohort characteristics
Frequency (%)
Patients 259 (100)
Pathologic tumor stage
pT1a 7 (2.7)
pT2a 26 (10.0)
pT2b 5 (1.9)
pT2c 132 (51.0)
pT3a 52 (20.1)
pT3b 36 (13.9)
ypT4 1 (0.4)
Lymph node status
pNx 1 (0.4)
pN0 237 (91.5)
pN1 21 (8.1)
Surgical margin status
Rx 2 (0.8)
R0 197 (76.1)
R1 60 (23.2)
Lymph vessel involvement
Lx 1 (0.4)
L0 188 (72.6)
L1 70 (27.0)
Vein involvement
Vx 1 (0.4)
V0 235 (90.7)
V1 23 (8.9)
Gleason Score
5 5 (1.9)
6 53 (20.5)
7 151 (58.3)
8 5 (1.9)
9 43 (16.6)
Cannot be estimated 2 (0.8)
HELPAP
Ib 4 (1.5)
IIa 78 (30.1)
IIb 96 (37.1)
IIIa 26 (10.0)
IIIb 53 (20.5)
Cannot be estimated 2 (0.8)

Eminaga et al.

Eminaga et al. BMC Medical Informatics and Decision Making 2012 12:141   doi:10.1186/1472-6947-12-141

Open Data